Carmela Hoefling, RN, MSN, APN-C, AOCNP, advanced practice nurse, Gastrointestinal/Hepatobiliary Oncology Program, Rutgers Cancer Institute of New Jersey, discusses the findings of a project on pancreatic treatment, care, and risk factors.
Carmela Hoefling, RN, MSN, APN-C, AOCNP, advanced practice nurse, Gastrointestinal/Hepatobiliary Oncology Program, Rutgers Cancer Institute of New Jersey, discusses the findings of a project on pancreatic treatment, care, and risk factors.
Hoefling says she has taken care of and treated many patients with pancreatic cancer. Pancreatic cancer is a notoriously devastating disease that is usually discovered in the later stages due to its lack of early-stage symptoms. By uncovering ways to diagnose the disease earlier, patients would be able to undergo surgery, which offers the best chance of cure and better overall prognosis, Hoefling says.
Hoefling also mentions that by making healthy lifestyle choices, such as not smoking, patients can better protect themselves from developing pancreatic cancer and other cancers as well.
Addition of Concomitant TTFields Induces OS Benefit in Unresectable Pancreatic Cancer
December 4th 2024The phase 3 PANOVA-3 trial, designed to evaluate concomitant treatment with tumor treating fields and chemotherapy, met its primary end point of overall survival in unresectable, locally advanced pancreatic adenocarcinoma.